In terms of vascular pathophysiology, antiphospholipid antibodies (aPL) and β2GPI activate endothelial cells and subsequently regulate serotonin and endothelin-1, which is involved in vasoconstriction and leads to migraine aura (58, 59). Here, EDN1 is linked to migraine disorder.